Appointed
Terry Kohler
Chief Financial Officer
OptiNose, Inc.
On October 7, 2024, OptiNose, Inc. (the “Company”) appointed Terry Kohler as the Company’s Chief Financial Officer.
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3751–3800 of 18625
On October 7, 2024, OptiNose, Inc. (the “Company”) appointed Terry Kohler as the Company’s Chief Financial Officer.
Khalid Nasser A.S. Al-Thani on a position as Chairman and CEO
James Peter Thorp will assume the position of CFO
Brian J. Harris has been appointed as Chief Financial Officer of the Company, effective October 7, 2024
On October 1, 2024, the Company and Ms. Beemish entered into a Separation and General Release Agreement, dated October 1, 2024 (the “Separation Agreement”), pursuant to which Ms. Beemish will receive, upon execution of a customary release and the completion and termination of the Consulting Agreement (as discussed below), payment of $170,238, payable in equal monthly installments over a six-month period.
Umesh Mahajan has become Co-Chief Investment Officer of the Company in addition to remaining Chief Financial Officer and Secretary of the Company
Andreas Bodmeier has replaced Scott Gordon as Chief Executive Officer of the Company
On October 1, 2024, Tom Reilly notified Amarin Corporation plc (the “Company”) of his decision to voluntarily resign as Executive Vice President, Chief Financial Officer and Head of Global HR & Finance, effective October 23, 2024, to pursue another opportunity.
In the interim, the Company’s Vice President, Global Controller, Peter Fishman, will assume the duties as principal financial officer and principal accounting officer of the Company, reporting to the CEO, Aaron Berg, until the Company appoints a permanent replacement.
On October 7, 2024, Benchmark Electronics, Inc. (the “Company”) announced the appointment of Bryan Schumaker, 48, as Executive Vice President (EVP), Chief Financial Officer (CFO) and Principle Accounting Officer.
O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.
O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.
On October 2, 2024, Ali Manav agreed to become the Acting Chief Executive Officer of Basanite, Inc. (the “Company”) through June 30, 2025.
The Company has determined that it will terminate the employment of Messrs. Lorber, Lampen, Kirkland and Bell, with such terminations becoming effective on the Closing Date but following the Closing.
The Company has determined that it will terminate the employment of Messrs. Lorber, Lampen, Kirkland and Bell, with such terminations becoming effective on the Closing Date but following the Closing.
Erika Jones, the Company’s Senior Vice President, Finance and Corporate Controller, and principal accounting officer, was appointed as principal financial officer of the Company.
On October 7, 2024, Black Diamond Therapeutics, Inc. (the “Company”) terminated Fang Ni, Pharm. D. without Cause (as such term is defined in his employment agreement with the Company, which was filed as Exhibit 10.12 to the Company’s Annual Report on Form 10-K filed on March 9, 2023 (the “Employment Agreement”)) as Chief Business Officer, Chief Financial Officer and principal financial officer of the Company, in each case, effective as of October 7, 2024
the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) appointed Steven Bailey as the Company’s Chief Financial Officer, effective March 1, 2025
Effective October 7, 2024 (the “Appointment Date”), the Board of Nuvation Bio Inc. (the “Company”) appointed Philippe Sauvage as the Company’s Chief Financial Officer and Principal Financial Officer.
On October 6, 2024, the Board of Directors (the “Board”) of the Company appointed Brian Krzanich as President and Chief Executive Officer (and “principal executive officer”) of the Company, effective October 7, 2024.
the Eastside Board of Directors appointed Christopher Moe, the Chief Financial Officer of Beeline, to serve as the Chief Financial Officer of Eastside.
promoted Angela Walsh from her prior role of Senior Vice President of Finance to the Company’s Chief Financial Officer, effective immediately upon the Closing on October 7, 2024
On October 1, 2024, Assure Holdings Corp. (the “Company”) appointed John Price to act as the Company’s Chief Financial Officer beginning October 1, 2024.
On September 13, 2024, Paul Webster, Interim Chief Financial Officer, tendered his resignation to the Company to be effective October 1, 2024.
On October 6, 2024, the Board appointed Jatinder Dhaliwal, a member of the Board, to serve as Chief Executive Officer of the Company, effective immediately.
On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their intention to resign for their respective positions, effective immediately.
On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their intention to resign for their respective positions, effective immediately.
the Compensation Committee of the Board of Directors of the Company approved the appointment of Michael Arthur as Chief Financial Officer, effective as of November 8, 2024.
Robert Kaiden will be resigning from his position as Chief Financial Officer at Inspirato Incorporated (the “Company”) effective as of November 8, 2024.
On October 3, 2024, Ribbon Communications Inc. (the “Company”) announced the appointment of John Townsend as Executive Vice President, Chief Financial Officer of the Company, effective upon the earlier of the filing of the Company’s Form 10-Q for the quarter ended September 30, 2024 and November 1, 2024 (the “Effective Date”).
As previously reported, Miguel Lopez, the Company’s current Executive Vice President, Chief Financial Officer, is retiring from the Company following the filing of the Company’s Form 10-Q for the quarter ended September 30, 2024.
Effective September 30, 2024, Mr. Jornayvaz resigned from all positions with the Company and its subsidiaries and affiliates, including as the Chief Executive Officer and as a member of its Board of Directors (the “Board”).
Joseph La Rosa, the Chief Executive Officer and the Chairman of the Board of Directors (the “Board”), was appointed to also temporarily serve as the interim Chief Financial Officer of the Company while the Company conducts its search for a successor, effective as of October 1, 2024.
Effective as of September 30, 2024, Kent Metzroth resigned from his position as Executive Vice President and Chief Financial Officer of the Company.
On October 1, 2024, Art’s-Way Manufacturing Co., Inc. (the “Company”) and David A. King, the Company’s Chief Executive Officer since 2020, mutually agreed to terminate Mr. King’s employment agreement and employment with the Company effective immediately.
On October 4, 2024, the Company’s Board of Directors appointed Marc H. McConnell, Chairman of the Company’s Board of Directors, to serve as President and Chief Executive Officer, effective immediately.
Effective October 1, 2024, Mr. Ari Olgun (“ Mr. Olgun ”) was appointed to serve as Interim Chief Financial Officer (“ Interim CFO ”) to fill the vacancy created by Mr. Watanabe’s departure from the Company.
Effective as of September 30, 2024 (the “ Departure Effective Date ”), following the expiration of his employment agreement dated September 30, 2021, Mr. Neil Watanabe (“ Mr. Watanabe ”), the Company’s Chief Financial Officer (“ CFO ”), departed from his role as CFO of the Company after three years of service to pursue other opportunities outside of the Company.
On October 1, 2024, the Board of Directors appointed Vincent Paul (VP) Berger II as Executive Vice President (“EVP”) and CFO, effective December 29, 2024, to succeed Mr. Bridges as the Corporation’s principal financial officer.
On September 27, 2024, Marshall H. Bridges notified HNI Corporation (the “Corporation” or “HNI”) of his decision to retire as Senior Vice President (“SVP”) and Chief Financial Officer (“CFO”), effective December 28, 2024.
On September 30, 2024, Brian Scott notified the Company of his intention to resign from his position as the Company’s Executive Vice President and Chief Financial Officer, effective November 20, 2024.
Dawn Hooper, the Company’s Senior Vice President, Controller will serve as the Company’s interim principal financial officer effective November 1, 2024, and as Interim Chief Financial Officer effective upon Mr. Scott’s departure until such time that a successor Chief Financial Officer is appointed.
On October 3, 2024, AMN Healthcare Services, Inc. (“AMN” or the “Company”) announced that Brian Scott will join AMN as its Chief Financial Officer and Chief Operating Officer (“CFO/COO”) reporting to Cary Grace, AMN’s President and Chief Executive Officer.
the departure of Jeffrey Knudson from his role as the Company’s CFO, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare industry.
the following individuals were elected as officers of the Company in each case until their successors are chosen and qualify in their stead or until their earlier death, resignation or removal: ● Jill Bruning, Chief Technology Officer ● Steven J. Demetriou, Executive Chair ● John Heller, Chief Executive Officer ● Travis B. Johnson, Chief Financial Officer and Chief Accounting Officer ● Sean Mullen, Chief Growth Officer ● Stuart I. Young, Chief Legal Officer
the following individuals were elected as officers of the Company in each case until their successors are chosen and qualify in their stead or until their earlier death, resignation or removal: ● Jill Bruning, Chief Technology Officer ● Steven J. Demetriou, Executive Chair ● John Heller, Chief Executive Officer ● Travis B. Johnson, Chief Financial Officer and Chief Accounting Officer ● Sean Mullen, Chief Growth Officer ● Stuart I. Young, Chief Legal Officer
replacing David I. Bruce in such roles
On October 1, 2024, the board of directors (the “Board”) of IRIDEX Corporation (the “Company”) appointed Patrick Mercer as its Chief Executive Officer and designated Mr. Mercer as the Company’s principal executive officer for purposes of the rules and regulations of the Securities and Exchange Commission (the “SEC”), effective as of such date, replacing David I. Bruce in such roles.
On October 3, 2024, the Company also announced that Sheamus Toal will be leaving his positions as Chief Operating Officer and Chief Financial Officer, effective December 13, 2024.
Mary Beth Harler, M.D. has been appointed as the Company’s Chief Executive Officer, effective as of the Effective Date, and as a member of the Board (initial term ending at the annual stockholder meeting in 2025), effective as of October 1, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.